- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Genetically predicted high BP and LDL-C increase risk of CHD independent of age
The impact of blood pressure and cholesterol levels on coronary heart disease (CHD) risk across different life stages has always been a subject of uncertainty. A recent study by the Nelson Wang and team utilized data from the UK Biobank and looked into the long term implications of elevated systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-C) on CHD risk. The findings of the study were published in PloS One.
The study included 136,648 participants for LDL-C, 135,431 for SBP, and 24,052 CHD cases. The study assessed the duration of exposure to these risk factors on CHD risk. Univariable analyses revealed a consistent association between higher LDL-C and SBP and increased odds of incident CHD in individuals aged ≤55, ≤60, and ≤65 years after stratified by age at enrollment. Importantly, multivariable MR analyses demonstrated that exposure to elevated LDL-C/SBP in early life (≤55 years) was independently associated with a higher CHD risk, irrespective of later-life levels (age >55 years) (odds ratio 1.68, 95% CI 1.20–2.34 per 1 mmol/L LDL-C, and odds ratio 1.33, 95% CI 1.18–1.51 per 10 mmHg SBP).
The findings highlight a crucial connection between genetically predicted SBP/LDL-C and CHD risk, transcending age. Independently of later-life levels, increased SBP and LDL-C in early to middle life emerged as potent contributors to increased CHD risk. This highlights the significance of lifelong control of these risk factors, specially in younger individuals with the risk of CHD accumulating throughout life. The study illuminates a pivotal aspect of cardiovascular health by emphasizing the need for early interventions and sustained efforts in managing these modifiable risk factors to reduce the lifelong burden of coronary heart disease.
Source:
Wang, N., Mustafa, R., Zuber, V., Rodgers, A., & Dehghan, A. (2023). Association between systolic blood pressure and low-density lipoprotein cholesterol with coronary heart disease according to age. PloS One, 18(12), e0295004. https://doi.org/10.1371/journal.pone.0295004
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751